Dan Spira
Director/Board Member chez NEXT SCIENCE LIMITED
Fortune : 159 483 $ au 31/03/2024
Profil
Dan Spira is currently the Group Chief Executive Officer at iNova Pharmaceuticals (Australia) Pty Ltd.
and an Independent Non-Executive Director at Next Science Ltd.
He previously worked as the Chief Marketing Officer, VP & Country Manager at Johnson & Johnson and as the Vice President & General Manager-North America at Bausch Health Cos., Inc. Mr. Spira completed his undergraduate degree at The University of New South Wales.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEXT SCIENCE LTD
0,26% | 31/12/2022 | 752 172 ( 0,26% ) | 159 483 $ | 31/03/2024 |
Postes actifs de Dan Spira
| Sociétés | Poste | Début |
|---|---|---|
| NEXT SCIENCE LIMITED | Director/Board Member | 01/06/2017 |
iNova Pharmaceuticals (Australia) Pty Ltd.
 iNova Pharmaceuticals (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology iNova Pharmaceuticals Pty Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Australia. | Chief Executive Officer | 01/10/2017 |
Anciens postes connus de Dan Spira
| Sociétés | Poste | Fin |
|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | 01/01/2015 |
| JOHNSON & JOHNSON | Sales & Marketing | - |
Formation de Dan Spira
| The University of New South Wales | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| NEXT SCIENCE LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
iNova Pharmaceuticals (Australia) Pty Ltd.
iNova Pharmaceuticals (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology iNova Pharmaceuticals Pty Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Australia. | Health Technology |
